Infimer (Israel) Odds of Future Stock Price Finishing Under 0.0
| INFR Stock | ILA 60.40 0.10 0.17% |
Infimer |
Infimer Target Price Odds to finish below 0.0
The tendency of Infimer Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to 0.00 or more in 90 days |
| 60.40 | 90 days | 0.00 | near 1 |
Based on a normal probability distribution, the odds of Infimer to drop to 0.00 or more in 90 days from now is near 1 (This Infimer probability density function shows the probability of Infimer Stock to fall within a particular range of prices over 90 days) . Probability of Infimer price to stay between 0.00 and its current price of 60.4 at the end of the 90-day period is about 38.33 .
Assuming the 90 days trading horizon Infimer has a beta of -1.79. This usually indicates as returns on its benchmark rise, returns on holding Infimer are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Infimer is expected to outperform its benchmark. Moreover Infimer has an alpha of 1.6855, implying that it can generate a 1.69 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta). Infimer Price Density |
| Price |
Predictive Modules for Infimer
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Infimer. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Infimer's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Infimer Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Infimer is not an exception. The market had few large corrections towards the Infimer's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Infimer, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Infimer within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | 1.69 | |
β | Beta against NYSE Composite | -1.79 | |
σ | Overall volatility | 14.58 | |
Ir | Information ratio | 0.09 |
Infimer Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Infimer for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Infimer can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Infimer generated a negative expected return over the last 90 days | |
| Infimer has high historical volatility and very poor performance | |
| The company has accumulated 289 K in total debt. Infimer has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Infimer until it has trouble settling it off, either with new capital or with free cash flow. So, Infimer's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Infimer sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Infimer to invest in growth at high rates of return. When we think about Infimer's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 378 K. Net Loss for the year was (7.99 M) with loss before overhead, payroll, taxes, and interest of (899 K). | |
| Infimer has accumulated about 14 K in cash with (1.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 14.0% of the company shares are held by company insiders |
Infimer Technical Analysis
Infimer's future price can be derived by breaking down and analyzing its technical indicators over time. Infimer Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Infimer. In general, you should focus on analyzing Infimer Stock price patterns and their correlations with different microeconomic environments and drivers.
Infimer Predictive Forecast Models
Infimer's time-series forecasting models is one of many Infimer's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Infimer's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Infimer
Checking the ongoing alerts about Infimer for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Infimer help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Infimer generated a negative expected return over the last 90 days | |
| Infimer has high historical volatility and very poor performance | |
| The company has accumulated 289 K in total debt. Infimer has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Infimer until it has trouble settling it off, either with new capital or with free cash flow. So, Infimer's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Infimer sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Infimer to invest in growth at high rates of return. When we think about Infimer's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 378 K. Net Loss for the year was (7.99 M) with loss before overhead, payroll, taxes, and interest of (899 K). | |
| Infimer has accumulated about 14 K in cash with (1.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 14.0% of the company shares are held by company insiders |
Check out Infimer Backtesting, Infimer Valuation, Infimer Correlation, Infimer Hype Analysis, Infimer Volatility, Infimer History as well as Infimer Performance. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Complementary Tools for Infimer Stock analysis
When running Infimer's price analysis, check to measure Infimer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infimer is operating at the current time. Most of Infimer's value examination focuses on studying past and present price action to predict the probability of Infimer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Infimer's price. Additionally, you may evaluate how the addition of Infimer to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |